Prescribed List Changes: 1 September 2011

Information about the publication of Ministerial Decisions

A formal published “Ministerial Decision” is required as a record of the decision of a Minister (or an Assistant Minister where they have delegated authority) as they exercise their responsibilities and powers.

Ministers are elected by the States Assembly and have legal responsibilities and powers as “corporation sole” under the States of Jersey Law 2005 by virtue of their office and in their areas of responsibility, including entering into agreements, and under any legislation conferring on them powers.

An accurate record of “Ministerial Decisions” is vital to effective governance, including:

demonstrating that good governance, and clear lines of accountability and authority, are in place around decisions-making – including the reasons and basis on which a decision is made, and the action required to implement a decision
providing a record of decisions and actions that will be available for examination by States Members, and Panels and Committees of the States Assembly; the public, organisations, and the media; and as a historical record and point of reference for the conduct of public affairs

Ministers are individually accountable to the States Assembly, including for the actions of the departments and agencies which discharge their responsibilities.

The Freedom of Information Law (Jersey) Law 2011 is used as a guide when determining what information is be published. While there is a presumption toward publication to support of transparency and accountability, detailed information may not be published if, for example, it would constitute a breach of data protection, or disclosure would prejudice commercial interest.

A decision made on 29 July 2011:

Decision Reference: MD-S-2011-0059
Decision Summary Title :	Prescribed List Changes 1 September 2011		Date of Decision Summary:	29 July 2011
Decision Summary Author:	Policy Principal		Decision Summary: Public or Exempt?	Public
Type of Report: Oral or Written?	Written		Person Giving Oral Report:	N/A
Written Report Title :	WR - Prescribed List Changes 1 September 2011		Date of Written Report:	22 July 2011
Written Report Author:	Policy Principal		Written Report : Public or Exempt?	Public
Subject: Changes to be made to the Prescribed List (Jersey) as at 1 September 2011
Decision(s): The Minister approved the changes to the Prescribed List (Jersey) as recommended by the Pharmaceutical Benefit Advisory Committee on 6th July 2011. To be included from 1 September 2011 as green items (for initiation in primary or secondary care): Denosumab 60 mg/mL pre-filled syringe Dorzolamide 2%, timolol 0.5% preservative-free eye drops (Cospot) Dorzolamide 2% preservative-free eye drops (Trusopt) Levobunolol 0.5%, polyvinyl alcohol 1.4% preservative-free eye drops (Betagan) To be included as amber item (for initiation/stabilisation in secondary care before transfer to primary care) Rotigotine patches (dose in 24 hours) 1mg, 2 mg, 3 mg, 4 mg, 6 mg, 8 mg To give notice that the following items be generic only from 1 September 2011 Risedronate 35mg tablets Anastrozole 1mg tablets Pramipexole 180mcg tablets Pramipexole 700mcg tablets Pramipexole 88mcg
Reason(s) for Decision: The Pharmaceutical Benefit Advisory Committee met on 6 July 2011 and proposed the recommended changes to the Prescribed List (Jersey), effective from 1 September 2011. The changes represent best value amendments for approved medicines and ensure that General Practitioners have the choice available to them of modern, safe and effective medicines.
Resource Implications: The overall impact of the changes is a reduced drug expenditure of circa £83,000 in drug costs
Action required: Policy Principal to issue public notice listing amendments and notify all approved medical practitioners and approved contractors.
Signature:		Position: Minister
Date Signed:		Date of Decision (If different from Date Signed):